Int J Neurosci. 2024 May 14:1-9. doi: 10.1080/00207454.2024.2352780. Online ahead of print.
ABSTRACT
Objectives: This clinical, analytical, retro-prospective, auto-controlled, not randomized and not blinded study, aimed to investigate the association of changes in the serum glucose levels with the pre-and-post changes in the size tumor in mm3 in the Non-Functional pituitary adenomas.Methods: Pre-and post-surgical MRI, as well as the measurements in the serum glucose levels and immunohistochemical techniques were performed in all the patients in the study, with a mean followed-up until 208.57 days. A comparison was made between the reduction in tumor size of Hormonally active pituitary adenomas (HSPAs) vs NFPAs.Results: Seventy-four patients were included in this study, of whom, 46 were NFPAs. The decrease in the NFPAs tumor size after surgery was statistically significant (P = < 0.0001). The Mean of the differences of both type of tumors in mm3 were -9552 ± 10287. Pre-surgery, the mean of the HSPAs were 8.923 ± 2.078; and the NFPAs were 14.161 ± 1.912. The differences in the tumor size were statistically significant (P = 0.039). Post-surgical, the mean of the HSPAs were 2.079 ± 971, with a (P = 0.14): and the NFPAs were 4.609 ± 1.205.After surgery of the NFPAs, most of the patients-maintained serum levels ≤ 100 mg/dL, with a statistical significance (P = <0.0003).Conclusion: This study demonstrates for the first time the correlation between the presence of pre-and post- surgical changes in the NFPAs, with modifications in the levels of serum glucose, and the comparison, pre- and post-surgical between the tumor size of HSPAs and NFPAs.
PMID:38742394 | DOI:10.1080/00207454.2024.2352780
